Rizatriptan Benzoate
Product Images NDC 53002-1713

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 53002-1713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl530021713)

Label Image (Lbl530021713)
FDA Label Image

Rizatriptan 01

Rizatriptan 01
FDA Label Image

Rizatriptan 02

Rizatriptan 02
The text seems to be a tabular format representing estimated probability of response for different drugs. The drugs mentioned in the table are "Placebo," "Rizatriptan Benzoate Tablets 5 mg," and "Rizatriptan Benzoate Tablets 10 mg." It appears that the probability of response varies for each drug across the different percentages mentioned in the table. However, without more context or information, it's challenging to provide more details.*
FDA Label Image

Rizatriptan 03

Rizatriptan 03
FDA Label Image

Rizatriptan 04

Rizatriptan 04

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.